Here are the top health news for the day:
NMC requires video recording of annual MBBS exams for renewal permissions
The National Medical Commission (NMC) has directed medical colleges across the country to furnish video recordings of the forth-coming annual MBBS examinations of every phase in order to be granted renewal of permissions.
Highlighting that the submission of such video recordings along with the completed Standard Assessment Form- C is necessary to be allowed renewal permission and if the colleges fail to submit such info, they shall have to face appropriate action as deemed fit.
This announcement was made by the Undergraduate Medical Education Board (UGMEB) of NMC through the notice dated February 06, 2024, where the Apex Medical Commission also informed that all the permitted seats stand recognized as per MSMER 2023 dated 19th September, 2023.
For the full story, check out the link given below:
Furnish Video Recordings Of Annual MBBS Exams Or No Renewal Permissions: NMC Tells Medical Colleges
IMA urges NMC to reevaluate implementation of National Exit Test
Opposing the National Medical Commission's (NMC) plans for conducting the National Exit Test (NExT) for medical graduates, the Indian Medical Association (IMA) has opined that since the standards of medical education across all academic institutions vary, testing the entire country with one test would not be "feasible".
In a letter addressed to the Chairman of NMC, Dr B.N.Gangadhar, the association has highlighted that the medical colleges across the country are facing inadequate technical infrastructure, and faculty training and support. Therefore, IMA has stated that NMC should not proceed with NExT until these prerequisites are duly satisfied.
For the full story, check out the link given below:
Reconsider Implementation Of National Exit Test: IMA To NMC
NPPA sets prices for various FDCs containing Sitagliptin and Linagliptin
The National Pharmaceutical Pricing Authority (NPPA) has announced that it has fixed retail prices of 39 formulations under the Drugs (Prices Control) Order, 2013. The price fixation is based on the decision of the 120th Authority meeting dated 24.01.2024.
The formulations whose prices have been fixed include Prosperity Drugs and Torrent Pharma's Paracetamol and Dicyclomine Hydrochloride Tablets, Abbott India's Zolpidem Tartrate Prolonged release tablets, Pure and cure Healthcare and Dr Reddy's Labs' Rosuvastatin plus Clopidogrel Capsules, Curetech Skincare and J.B. Chemicals & Pharma's Diclofenac Diethylamine, Virgin Linseed Oil, Methyl Salicylate, Menthol & Capsacin Gel.
The list further includes Synokem Pharmaceuticals and Mankind Pharma's Linagliptin, Metformin Hydrochloride (Extended Release) Tablets, Mascot Health Series and Lupin's Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets, Sun Pharma Laboratories' Dapagliflozin, Metformin Hydrochloride Extended Releaseand Glimepiride Tablets.
For the full story, check out the link given below:
NPPA Fixes Price For Various FDCs Having Sitagliptin, Linagliptin
Two BHU students arrested for allegedly assaulting doctor
In a jaw-dropping incident, two final-year students of the Banaras Hindu University (BHU) were arrested on Monday for allegedly sexually assaulting a 32-year-old male doctor and forcing him to perform unnatural sex.
The accused locked the doctor in the hostel room and robbed him of Rs 60,000 with other valuable gold items.
According to the police, the accused students called the doctor for a medical emergency at the university's hostel. They then imprisoned him in the hostel room, physically assaulted him, coerced him into engaging in non-consensual sexual acts, and robbed him by threatening to share a nude video of him on social media.
Along with these two students, three others were also in the hostel room when the incident occurred.
For the full story, check out the link given below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.